Product Details for NDA 050674
VANTIN (CEFPODOXIME PROXETIL)
EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CEFPODOXIME PROXETIL
Proprietary Name: VANTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050674
Product Number: 001
Approval Date: Aug 7, 1992
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Discontinued
Patent and Exclusivity Information
VANTIN (CEFPODOXIME PROXETIL)
Proprietary Name: VANTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050674
Product Number: 001
Approval Date: Aug 7, 1992
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CEFPODOXIME PROXETIL
Proprietary Name: VANTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050674
Product Number: 002
Approval Date: Aug 7, 1992
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: VANTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N050674
Product Number: 002
Approval Date: Aug 7, 1992
Applicant Holder Full Name: PHARMACIA AND UPJOHN CO
Marketing Status: Discontinued
Patent and Exclusivity Information